Clinical Trials
13 trialsNCT03784924 2026-01-08
P-MRI
University of Michigan
Recruiting
NCT06209853 2024-07-15
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient
Assiut University
Recruiting
NCT05500846 2024-06-21
PROCRY
Kyoto Prefectural University of Medicine
Phase NA Active not recruiting
NCT01697384 2024-01-02
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
Endo Pharmaceuticals
Phase 3 Completed
NCT00987753 2023-05-25
Study Evaluating the Safety and Tolerability of L-377202
University of Alabama at Birmingham
Phase 1/2 Completed
NCT00911079 2021-07-07
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
University of California, San Francisco
Phase NA Terminated
NCT02013180 2019-04-16
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
Bagcilar Training and Research Hospital
Completed
NCT02047253 2018-12-19
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
University of Alabama at Birmingham
Phase 2 Completed
NCT00562341 2018-08-23
Effect of Lap-Band Induced Weight Loss on Serum PSA Levels
Maimonides Medical Center
Withdrawn
NCT01672411 2013-02-26
Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer
University Of Perugia
Completed
NCT01220817 2012-04-06
Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study
POM Wonderful LLC
Phase 2 Completed
NCT00596895 2011-09-20
Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer
University of Florida
Phase 2 Completed
NCT00764166 2008-10-01
RisingPSA
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown